Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Qutenza Versus Pregabalin in Subjects With Peripheral Neuropathic Pain: an Open-label, Randomized, Multicenter, Non-inferiority Efficacy and Tolerability Study

NCT01713426 is registered in ClinicalTrials.gov with Astellas Pharma Europe Ltd. as lead sponsor.

NCT NCT01713426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01713426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Qutenza Versus Pregabalin in Subjects With Peripheral Neuropathic Pain: an Open-label, Randomized, Multicenter, Non-inferiority Efficacy and Tolerability Study
Lead sponsor
Astellas Pharma Europe Ltd.
Phase
Phase 4
Overall status
Completed
Start date
July 11, 2012
Completion date
September 26, 2013
Enrollment
568 (actual)
Sites
98

Conditions

As the registry lists them; a condition with its own page is linked.

non-diabetic painful peripheral polyneuropathy, peripheral nerve injury (pni), postherpetic neuralgia (phn)